Aspire Biopharma Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aspire Biopharma Holdings Inc's ROI in the second quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Aspire Biopharma Holdings Inc 's return on investment (ROI) in its second quarter of 2026

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	12	4	-6	-11	-10
Return On Investment (TTM)	2303.24 %	201.58 %	-	-	-
ASBP's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-11	-12	-24	-21	-19

ASBP Company Profile >> Back to ASBP Roi Comparisons >> See Annual ASBP Return On Investment

Return On Investment ASBP's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Aspire Biopharma Holdings Inc's II. Quarter Investments	$ 12 Millions	ASBP's Balance sheet
Aspire Biopharma Holdings Inc's II. Quarter Income	$ -1 Millions	Quarterly ASBP's Income Statement
ASBP's Income by Division		See ASBP's Income by Division

ASBP Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022
Total Investments in Millions	-6	-9	20	300	0
Y / Y Investment Growth	-	-	-93.47 %	-	-
Net Income in Millions	-24	-13	4	3	0
Y / Y Net Income Growth	-	-	33.65 %	-	-
Annual Return On Investment	-	-	22.8 %	1.11 %	-

Annual Roi Comment

Despite deterioration in net income, company improved ROI to in the fiscal year 2025, company improved ROI to 1.11 % compare to previous year.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ASBP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ASBP's Competitors
Subscribers only: Roi for Aspire Biopharma Holdings Inc's Suppliers
Subscribers only: Return On Investment for ASBP's Customers

Other Ratios
ASBP's Roa	ASBP's Inventory Turnover Ratio	ASBP's Growth Rates	ASBP's Dividend Statistics
	ASBP's Profitability Ratios	ASBP's Asset Turnover Ratio	ASBP's Dividend Growth
ASBP's Roe	ASBP's Valuation Ratios	ASBP's Financial Strength Ratios	ASBP's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Glucotrack Inc	843.28 %
Stablecoin Development Corporation	618.18 %

Date modified: 2026-09-02T19:46:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.